[HTML][HTML] Renal adverse reactions of tyrosine kinase inhibitors in the treatment of tumours: A Bayesian network meta-analysis

Y Xiong, Q Wang, Y Liu, J Wei, X Chen - Frontiers in Pharmacology, 2022 - frontiersin.org
Objectives: Tumours remain a serious threat to human life. Following rapid progress in
oncology research, tyrosine kinase inhibitors have been used to treat multiple tumour types …

Renal adverse reactions of tyrosine kinase inhibitors in the treatment of tumours: A Bayesian network meta-analysis

Y Xiong, Q Wang, Y Liu, J Wei… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives: Tumours remain a serious threat to human life. Following rapid progress in
oncology research, tyrosine kinase inhibitors have been used to treat multiple tumour types …

[HTML][HTML] Renal adverse reactions of tyrosine kinase inhibitors in the treatment of tumours: A Bayesian network meta-analysis

Y Xiong, Q Wang, Y Liu, J Wei… - Frontiers in Pharmacology, 2022 - ncbi.nlm.nih.gov
Objectives: Tumours remain a serious threat to human life. Following rapid progress in
oncology research, tyrosine kinase inhibitors have been used to treat multiple tumour types …

Renal adverse reactions of tyrosine kinase inhibitors in the treatment of tumours: A Bayesian network meta-analysis.

Y Xiong, Q Wang, Y Liu, J Wei, X Chen - Frontiers in Pharmacology, 2022 - europepmc.org
Objectives: Tumours remain a serious threat to human life. Following rapid progress in
oncology research, tyrosine kinase inhibitors have been used to treat multiple tumour types …

[引用][C] Renal adverse reactions of tyrosine kinase inhibitors in the treatment of tumours: A Bayesian network meta-analysis

Y Xiong, Q Wang, Y Liu, J Wei, X Chen - 2022 - europepmc.org
Objectives: Tumours remain a serious threat to human life. Following rapid progress in
oncology research, tyrosine kinase inhibitors have been used to treat multiple tumour types …